Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer

NCT01365910 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Interim analysis determined the study did not meet criteria to proceed

Conditions

Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IVA Colon Cancer
Stage IVA Rectal Cancer
Stage IVB Colon Cancer
Stage IVB Rectal Cancer

Interventions

DRUG: linifanib

Sponsor

Vanderbilt-Ingram Cancer Center